NCT06829576

Brief Summary

To compare health-related physical fitness parameters in Type 2DM patients with and without dyslipidemia.Cardiometabolic biomarkers glucose and lipid profile will be noted from medical records. Body composition, functional capacity will be assessed with a six-minute walk test, peripheral muscle strength with a dynamometer, and physical activity level with a pedometer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 17, 2025

Completed
Last Updated

February 17, 2025

Status Verified

February 1, 2025

Enrollment Period

Same day

First QC Date

January 31, 2025

Last Update Submit

February 14, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Muscle strength

    M. Quadriceps muscle strength and hand grip strength measurement will be used to evaluate peripheral muscle strength. Hand-held dynamometer will be used to evaluate quadriceps muscle strength and hand grip strength.

    1 day

  • Funcitonal capacity

    Submaximal functional exercise capacity of the participants will be evaluated with the six-minute walk test.

    1 day

  • Waist circumference

    Waist circumference will be measured at belly level with the patient in an upright position during expiration, with both feet bearing equal weight.

    1 day

  • Hip circumference

    Hip circumference will be measured at the level of the greater femoral trochanter, with the patient in an upright position, with both feet bearing equal weight.

    1 day

  • Body fat-muscle ratios

    Body fat-muscle ratios;These measurements will be determined by bioelectrical impedance.

    1 day

Secondary Outcomes (4)

  • Physical activity level (step count)

    1 week (seven days)

  • Glucose profile

    1 day

  • Glucose profile

    1 day

  • Lipid profile

    1 day

Eligibility Criteria

Age35 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Followed up in the Diabetes Polyclinic, Department of Internal Medicine, Endocrinology and Metabolic Diseases, Istanbul University, Istanbul Faculty of Medicine

You may qualify if:

  • Having been diagnosed with Type 2 DM for at least 1 year,
  • Having an HbA1c value between 6.5-11%,
  • Being between the ages of 35-65,
  • Knowing how to read and write Turkish,
  • Having signed the informed consent form

You may not qualify if:

  • Lack of cooperation
  • Patients with peripheral or central serious neurological disorders
  • Patients with uncontrolled hypertension and uncontrolled arrhythmia
  • Pregnant or lactating patients
  • Patients with diabetic ulcers or neuropathy
  • Chronic renal failure (eGFR\<30 ml/min)
  • Chronic liver disease (ALT/AST\<3X Upper limit of normal)
  • Patients with serious respiratory system disease
  • Patients with cardiac pacemakers
  • History of previous stroke or myocardial infarction
  • Presence of lower and upper extremity orthopedic problems that may prevent the application of clinical tests

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Galata University

Istanbul, Turkey (Türkiye)

Location

Study Officials

  • Buket Akinci, Assoc.Prof

    Biruni University

    STUDY DIRECTOR
  • Safak Yigit, PhD(c)

    Istanbul Galata University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PT, PhD(c)

Study Record Dates

First Submitted

January 31, 2025

First Posted

February 17, 2025

Study Start

June 1, 2022

Primary Completion

June 1, 2022

Study Completion

December 30, 2022

Last Updated

February 17, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations